高级检索
当前位置: 首页 > 详情页

Regional difference in the susceptibility of non-alcoholic fatty liver disease in China

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Fudan Univ, Fudan Inst Metab Dis, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [2]Zhengzhou Univ, Dept Endocrinol & Metab, Affiliated Hosp 1, Zhengzhou, Peoples R China; [3]Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Endocrine & Metab Dis, Key Lab Endocrine Tumors,Ruijin Hosp,Sch Med, Minist Shanghai,Shanghai Inst Endocrine & Metab D, Shanghai, Peoples R China; [4]Harbin Med Univ, Dept Endocrinol & Metab, Affiliated Hosp 2, Harbin, Peoples R China; [5]Shenzhen Univ, Dept Endocrinol & Metab, Gen Hosp, Shenzhen, Peoples R China; [6]Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Tianjin Key Lab Metab Dis,Tianjin Metab Dis Hosp, Tianjin, Peoples R China; [7]Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [8]Third Cent Hosp Tianjin, Dept Endocrinol & Metab, Tianjin, Peoples R China; [9]Kunming Med Univ,Dept Endocrinol & Metab,Affiliated Hosp 1,Kunming,Yunnan,Peoples R China; [10]Nanjing Univ, Dept Endocrinol & Metab, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [11]Qingdao Univ, Dept Endocrinol & Metab, Affiliated Hosp, Coll Med, Qingdao, Peoples R China; [12]Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai, Peoples R China; [13]Southeast Univ, Dept Endocrinol & Metab, Zhongda Hosp, Sch Med, Nanjing, Peoples R China; [14]Ningxia Med Univ, Endocrine Testing Ctr, Gen Hosp, Yinchuan, Ningxia, Peoples R China; [15]Shandong Univ, Dept Endocrinol, Qilu Hosp, Qingdao, Peoples R China; [16]Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai, Peoples R China; [17]Sichuan Univ, West China Hosp, Dept Nephrol, Chengdu, Peoples R China; [18]Fudan Univ, Dept Clin Nutr, Zhongshan Hosp, Ctr Clin Epidemiol,EBM, Shanghai, Peoples R China
出处:
ISSN:

关键词: pre-diabetes liver fat type 2 diabetes non-alcoholic fatty liver disease

摘要:
Introduction Non-alcoholic fatty liver disease (NAFLD) is a global health problem with high geographic heterogeneity. We aimed to investigate regional-specific concomitant rate of NAFLD and quantitative relationship between liver fat content (LFC) and glucose metabolism parameters in representative clinical populations from six provinces/municipalities of China. Research design and methods A total of 2420 eligible Han Chinese were enrolled consecutively from 10 clinics of obesity, diabetes and metabolic diseases located at six provinces/municipalities of China, and divided into North (Tianjin, Shandong and Heilongjiang) and South (Shanghai, Jiangsu and Henan) groups according to their geographical latitude and proximity of NAFLD concomitant rate. LFC was assessed by a quantitative ultrasound method. Multivariate regression models and analysis of covariance were used to assess the regional difference in the risk of NAFLD. Results The concomitant rate of NAFLD was 23.3%, 44.0% and 55.3% in individuals with normal glucose tolerance (NGT), pre-diabetes and diabetes, respectively. A higher concomitant rate of NAFLD was found in the participants from the North comparing with the South group, regardless of glucose metabolism status (34.7% vs 16.2% in NGT, 61.5% vs 34.7% in pre-diabetes and 67.1% vs 48.1% in diabetes). This regional difference remained significant after adjustment for age, gender, alcohol drinking, cigarette smoking, confounding metabolic parameters and liver enzymes. For any given blood glucose, participants from the North had higher LFC than those from the South group. Conclusions Half of Han Chinese with pre-diabetes/type 2 diabetes had NAFLD, and the individuals from the North cities were more susceptible to NAFLD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2020]版:
Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Fudan Univ, Fudan Inst Metab Dis, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China;
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:56916 今日访问量:2 总访问量:1772 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)